EATG, News ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen November 18, 2016 1046
Facebook Twitter Google+ Post Views: 1,046 ARTHIV/AIDSTreatment Share the News Facebook Twitter VKontakte Google+ Fast-track update on investments needed in the AIDS responce. UNAIDS 2016. Reference. European Antibiotic Awareness Day 2016 Related News 1371 Behavioral intervention reduces HIV transmission risk in young transgender women 1720 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 1702 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 1613 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2070 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
1720 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
